These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin. Meneilly GS; Ryan AS; Minaker KL; Elahi D J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971 [TBL] [Abstract][Full Text] [Related]
4. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405 [TBL] [Abstract][Full Text] [Related]
5. Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes. Bergmann NC; Lund A; Gasbjerg LS; Jørgensen NR; Jessen L; Hartmann B; Holst JJ; Christensen MB; Vilsbøll T; Knop FK J Clin Endocrinol Metab; 2019 Jul; 104(7):2953-2960. PubMed ID: 30848791 [TBL] [Abstract][Full Text] [Related]
6. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324 [TBL] [Abstract][Full Text] [Related]
7. Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes. Christensen MB; Lund AB; Jørgensen NR; Holst JJ; Vilsbøll T; Knop FK J Endocr Soc; 2020 Sep; 4(9):bvaa097. PubMed ID: 32904711 [TBL] [Abstract][Full Text] [Related]
8. Role of gastrointestinal hormones in postprandial reduction of bone resorption. Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; Krarup T; Holst JJ; Christiansen C J Bone Miner Res; 2003 Dec; 18(12):2180-9. PubMed ID: 14672353 [TBL] [Abstract][Full Text] [Related]
9. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954 [TBL] [Abstract][Full Text] [Related]
10. Effects of endogenous GIP in patients with type 2 diabetes. Stensen S; Gasbjerg LS; Krogh LL; Skov-Jeppesen K; Sparre-Ulrich AH; Jensen MH; Dela F; Hartmann B; Vilsbøll T; Holst JJ; Rosenkilde MM; Christensen MB; Knop FK Eur J Endocrinol; 2021 May; 185(1):33-45. PubMed ID: 33886495 [TBL] [Abstract][Full Text] [Related]
11. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling. Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074 [TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes. Christensen MB; Calanna S; Holst JJ; Vilsbøll T; Knop FK J Clin Endocrinol Metab; 2014 Mar; 99(3):E418-26. PubMed ID: 24423311 [TBL] [Abstract][Full Text] [Related]